Skip to content

Effectiveness and safety of Yizhiqingxin Formula in treating patients with vascular dementia(stasis toxin syndrome)

Effectiveness and safety of Yizhiqingxin Formula in treating patients with vascular dementia(stasis toxin syndrome)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005592
Enrollment
Unknown
Registered
2022-02-03
Start date
2022-03-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vascular Dementia

Interventions

Group 2:analogue of Yizhiqingxin Formula
Group 1:Traditional Chinese Medicine Yizhiqingxin Formula

Sponsors

Xiyuan Hospital,China Academy of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 75 Years

Inclusion criteria

Inclusion criteria: Diagnostic criteria: ? American Psychiatric Association Diagnostic Manual and Statistical Manual of Mental Disorders Standard (DSM-IV); ?2002 Chinese Medical Association Neurology Branch "Draft Diagnostic Criteria for Vascular Dementia". Inclusion criteria: ?Age =45 years old and =75 years old, both male and female; women should be postmenopausal women who are infertile. ?Meet the above diagnostic criteria for dementia, VD diagnostic criteria and TCM syndrome diagnostic criteria, and the course of dementia is more than 3 months. ? The degree of CDR dementia was assessed as mild and moderate dementia (CDR=1.0, 2.0). ? Mini-Mental State Examination Scale (MMSE) = 26 points, = 10 points. ?HIS points = 7 points. ? Volunteers and signed informed consent. ? Have a correct understanding of the significance of drug research, and have good compliance with the observation and evaluation of researchers. ? Have a certain degree of education, can read simple newspaper articles and write simple small articles in the past.

Exclusion criteria

Exclusion criteria: ? Alzheimer's disease patients with HIS score =4 points and mixed dementia patients with 5-6 points. ? Patients with dementia and depression were excluded. ? Patients with CDR=3.0. ? Dementia patients after cerebral hemorrhage or large cortical infarction. ? Those with severe neurological deficits. ? Patients with severe heart, liver and kidney function. ? Patients who have used any history of drugs that may affect cognitive function in the past 3 months.

Design outcomes

Primary

MeasureTime frame
neuropsychological tests;

Countries

China

Contacts

Public ContactLi Hao
xyhplihao1965@126.com13311382093

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026